Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Apiam Animal Health Ltd. ( (AU:AHX) ) is now available.
Trading in Apiam Animal Health’s shares on the ASX will be suspended at the close of 6 February 2026 after court approval of a scheme of arrangement under which Pepper Bidco Pty Ltd and Pepper Holdco Limited, entities controlled by Adamantem Capital Fund II, will acquire all issued shares in the company. The suspension marks the final stages of Apiam’s transition to private ownership, removing it from public markets and consolidating control under Adamantem, with implications for existing shareholders as they are cashed out of their holdings.
The most recent analyst rating on (AU:AHX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Apiam Animal Health Ltd. stock, see the AU:AHX Stock Forecast page.
More about Apiam Animal Health Ltd.
Apiam Animal Health Limited (ASX: AHX) operates in the animal health industry, providing veterinary and related services and products, with a focus on livestock and companion animals across Australia.
Average Trading Volume: 278,174
Technical Sentiment Signal: Buy
Current Market Cap: A$160.1M
See more insights into AHX stock on TipRanks’ Stock Analysis page.